A spindle cell variant of diffuse large B-cell lymphoma possesses genotypic and phenotypic markers characteristic of a germinal center B-cell origin

Modern Pathology

Volumn 19, Issue 2, 2006, Pages 299-306

  Carbone, Antonino ^a   Gloghini, Annunziata ^b   Libra, Massimo ^c   Gasparotto, Daniela ^b   Navolanic, Patrick M ^c   Spina, Michele ^b   Tirelli, Umberto ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Diffuse large B cell lymphoma; Lymphoma; Spindle cell

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IDARUBICIN; LACTATE DEHYDROGENASE; PREDNISONE; PROTEIN; PROTEIN BCL 6; PROTEIN MUM1; RITUXIMAB; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CELL MATURATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE PHENOTYPE CORRELATION; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MARKER GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINDLE CELL; SPINDLE CELL LYMPHOMA; VAGINA;

ADULT; AGED; B-LYMPHOCYTES; CLONE CELLS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; GENOTYPE; GERMINAL CENTER; HUMANS; KI-67 ANTIGEN; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; TUMOR MARKERS, BIOLOGICAL;

EID: 30944454675     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800540     Document Type: Article

References (31)

1. Warnke RA, Weiss LM, Chan JKC, et al. Tumors of the lymph nodes and spleen. In: Rosai J, Sobin LH (eds). Atlas of Tumor Pathology. Third Series, Fascicle 14. Armed Forces Institute of Pathology: Washinton, DC, 1994, pp 177-178.
2. Fung CHK, Anter S, Yonan T, et al. Actin-positive spindle cell lymphoma. Arch Pathol Lab Med 1993;117:1053-1055.
3. Chan JKC, Buchanan R, Fletcher CDM. Sarcomatoid variant of anaplastic large-cell Ki-1 lymphoma. Am J Surg Pathol 1990;14:983-988.
4. Wang J, Sun NC, Nozawa Y, et al. Histological and immunohistochemical characterization of extranodal diffuse large-cell lymphomas with prominent spindle cell features. Histopathology 2001;39:476-481.
5. Dahlin DC, Unni KK. Bone Tumors, General Aspects and Data on 8542 Cases, 4th edn. Charles C Thomas: Springfield, 1986, pp 208-226.
6. Perrone T, Frizzera G, Rosai J. Mediastinal diffuse large-cell lymphoma with sclerosis. A clinicopathologic study of 60 cases. Am J Surg Pathol 1986;10:176-191.
7. Kahlifa M, Buckstein R, Perez-Ordonez B. Sarcomatoid variant of B-cell lymphoma of the uterine cervix. Int J Gynecol Pathol 2003;22:289-293.
8. Ferrara G, Bevilacqua M, Argenziano G. Cutaneous spindle B-cell lymphoma: a reappraisal. Am J Dermatopathol 2002;24:526-527.
9. Cerroni L, El-Shabrawi-Caelen L, Fink-Puches R, et al. Cutaneous spindle-cell B-cell lymphoma: a morphologic variant of cutaneous large B-cell lymphoma. Am J Dermatopathol 2000;22:299-304.
10. Goodlad JR. Spindle-cell B-cell lymphoma presenting in the skin. Br J Dermatol 2001;145:313-317.
11. Kuppers R, Klein U, Hansmann M-L, et al. Cellular origin of human B-cell lymphomas. N Engl J Med 1999;341:1520-1529.
12. Carbone A, Gaidano G, Gloghini A, et al. Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood 1998;91:747-755.
13. H) in normal and malignant B cells. Am J Pathol 1998;153:1341-1346.
14. Pasqualucci L, Migliazza A, Fracchiolla N, et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci USA 1998;95:11816-11821.
15. Shen HM, Peters A, Baron B, et al. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 1998;280:1750-1752.
16. Capello D, Vitolo U, Pasqualucci L, et al. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood 2000;95:651-659.
17. Falini B, Fizzotti M, Pucciarini A, et al. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood 2000;95:2084-2092.
18. Gaidano G, Carbone A. MUM1: a step ahead toward the understanding of lymphoma histogenesis. Leukemia 2000;14:563-566.
19. Dogan A, Bagdi E, Munson P, et al. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. Am J Surg Pathol 2000;24:846-852.
20. Jaffe ES, Harris NL, Stein H, et al (eds). World Health Organization Classification of Tumors, Pathology and Genetics of Tumors of Haematopoietic and Lymphois Tissues. IARC Press: Lyon, 2001.
21. Carbone A, Gloghini A, Larocca LM, et al. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood 2001;97:744-751.
22. Thériault C, Galoin S, Valmary S, et al. PCR analysis of immunoglobulin heavy chain (IgH) and TcR-g chain gene rearrangements in the diagnosis of lymphoproliferative disorders: results of a study of 525 cases. Mod Pathol 2000;13:1269-1279.
23. Gaidano G, Pasqualucci L, Capello D, et al. Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. Blood 2003;102:1833-1841.
24. Carbone A, Gloghini A, Vaccher E, et al. KSHV/HHV-8-positive solid lymphomas. A tissue-based variant of primary effusion lymphoma. J Mol Diagn 2005;7:17-27.
25. Colomo L, Lopez-Guillermo A, Perales M, et al. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood 2003;101:78-84.
26. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-511.
27. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002;346:1937-1947.
28. Wright G, Tan B, Rosenwald A, et al. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci USA 2003;100:9991-9996.
29. Chang CC, McClintock S, Cleveland RP, et al. Immunohistochemical expression patterns of germinal center anc activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma. Am J Surg Pathol 2004;28:464-470.
30. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2003;103:275-282.
31. Carbone A, Gloghini A, Cozzi MR, et al. Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions. Implications for disease histogenesis and pathogenesis. Br J Haematol 2000;111:247-257.